Abstract:Over the past decade, clinicians, neurologists and neurosurgeons have been seeking all possible logical or empirical methods for improving the plight of the patient suffering from a massive stroke. As a result of this emphasis, an inroad has been made into the previous fatalistic attitude. Much has changed since Penfield commented, "The right of the aged and the hypertensive to die from apoplectic stroke undisturbed has been unchallenged for a very long time." I am keenly aware of the many misgivings and reservations pertaining to any therapy that is advocated for the acute and subacute phases of cerebrovascular ischemia or infarction, with or without an associated thrombosis or embolism. During the past few years, we have witnessed the ebb and flow of interest in stellate ganglion blocks; papaverine; nicotinic acid; intravenous histamine, procaine, aminophylline, or bicarbonate; inhalation of external or autogenous carbon dioxide; and anticoagulants. Each of these forms of therapy has been associated with a variable measure of success, as described in enthusiastic reports by capable observers. On occasion, the response of individual patients has been quite dramatic. The enthusiasm aroused for such therapy was dampened in short order, however, by a volley of criticisms voiced by other authorities. The greatest objections concerned the unpredictable course of acute nonhemorrhagic stroke in any given patient, and the failure of the treatment being advocated to lower the rates of morbidity and mortality significantly as compared with the rates in control groups of patients. Inasmuch as the author also found himself in the position of voicing similar arguments to his own colleagues, he waited two years after observing the striking effects of adrenal steroids in the first patient of his series before feeling justified in reporting these experiences in the form of a paper which includes the data on additional cases of favorable response observed in the interim. To date, the article by Russek ei al. (1) appears to be the only one in the standard literature dealing exclusively with the use of cortisone in the immediate treatment of apoplectic stroke. Very few studies have come to my attention in which the adrenocortical steroids were actively employed in the subacute hemiplegic phase of stroke (2, 3). Several reviews were published in 1956 and 1957 dealing with the management of cerebrovascular accidents; in 1 instance (4) no reference was made to the use of hormones, and in the other 2 only a sentence was devoted to the entire subject (5, 6). Indeed, the value of such therapy in cerebral infarction has actually been denied in some quarters (7). It should be emphasized that the use of cortisone and its analogs is not advo-

Higher-order Human Telomeric G-quadruplex DNA Metalloenzymes Enhance Enantioselectivity in the Diels-Alder Reaction.

Enantioselective Diels–Alder Reactions with G‐Quadruplex DNA‐Based Catalysts

Enantioselective sulfoxidation reaction catalyzed by a G-quadruplex DNA metalloenzyme.

Probing the Interaction of Copper Cofactor and Azachalcone Substrate with G-quadruplex of DNA Based Diels-Alderase by Site-Specific Fluorescence Quenching Titration.

Effect of Distance from Catalytic Synergy Group to Iron Porphyrin Center on Activity of G-Quadruplex/Hemin DNAzyme

Efficient Silver(I)‐Containing i‐Motif DNA Hybrid Catalyst for Enantioselective Diels–Alder Reactions

Topology of DNA G-Quadruplexes Can Be Harnessed in Holliday Junction-Based DNA Suprastructures to Control and Optimize Their Biocatalytic Properties

G-Quadruplex binding enantiomers show chiral selective interactions with human telomere

Relations Between the Loop Transposition of Dna G-Quadruplex and the Catalytic Function of Dnazyme

SUPPORTIVE ADRENOCORTICAL STEROID THERAPY IN ACUTE AND SUBACUTE CEREBROVASCULAR ACCIDENTS, WITH PARTICULAR REFERENCE TO BRAIN‐STEM INVOLVEMENT

How Proximal Nucleobases Regulate the Catalytic Activity of G-quadruplex/Hemin DNAzymes

A Push–Pull Mechanism Helps Design Highly Competent G-Quadruplex-DNA Catalysts

Binding of copper(II) polypyridyl complexes to DNA and consequences for DNA-based asymmetric catalysis.

E1A 12S in the absence of E1B or other cooperating oncogenes enables cells to overcome apoptosis.

Targeting Human Telomeric G-Quadruplex with Perfluoroalkyl Metal Phthalocyanine Derivatives

The Effect of Adenine Repeats on G-quadruplex/hemin Peroxidase Mimicking DNAzyme Activity.

A Catalytic and Selective Scissoring Molecular Tool for Quadruplex Nucleic Acids

Self-Assembly Nanostructure Induced by Regulation of G-Quadruplex DNA Topology Via a Reduction-Sensitive Azobenzene Ligand on Cells

Zippered G-quadruplex/hemin DNAzyme: exceptional catalyst for universal bioanalytical applications

In a first, natural selection defeats a biocontrol insect.

A Double Hemin Bonded G-Quadruplex Embedded in Metal-Organic Frameworks for Biomimetic Cascade Reaction